AMTI — Applied Molecular Transport. Share News
0.000.00%
Last trade - 00:00HealthcareSpeculativeMicro Cap
U.S. STOCKS ON THE MOVE-Exxon, Chevron, News Corp, Valneva
U.S. STOCKS ON THE MOVE-Expion360 Inc, Applied Molecular Transport, News Corp
Applied Molecular extends losses as bowel disease drug trial data disappoints
U.S. STOCKS ON THE MOVE-Expion360, Atai Life Sciences, Intercept Pharmaceuticals
U.S. STOCKS ON THE MOVE-Mersana Therapeutics, Tesla, Outlook Therapeutics
Applied Molecular down on disappointing data from ulcerative colitis drug trial
Brief: Applied Molecular Transport Announces Top-Line Phase 2 Results From Lombard Monotherapy Trial Of Oral Amt-101 In Patients With Moderate-To-Severe Ulcerative Colitis
Applied Molecular up on FDA's orphan drug tag for pouchitis treatment
Brief: Applied Molecular Transport Announces FDA Orphan Drug Designation Granted To Amt-101
U.S. RESEARCH ROUNDUP-Linkbancorp, Oyster Point Pharma, Viatris
Applied Molecular Transport Inc. reports results for the quarter ended in September - Earnings Summary
U.S. RESEARCH ROUNDUP-Linkbancorp, Oyster Point Pharma, Viatris
Brief: Applied Molecular Transport Inc Reports Q3 Loss Per Share Of $0.65
Applied Molecular Transport Inc. expected to post a loss of 65 cents a share - Earnings Preview
Brief: Applied Molecular Transport Completes Enrollment Of Phase 2 Lombard Monotherapy Trial Of Oral AMT-101 In Patients With Moderate-To-Severe Ulcerative Colitis
Applied Molecular Transport Inc. reports results for the quarter ended in June - Earnings Summary
Brief: Applied Molecular Transport Reports Second Quarter 2022 Financial Results And Provides Corporate Update
NASDAQ RESUMED AT 09:38 AM
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 09:32 AM